Tourmaline Bio (TRML) Institutional Ownership $18.00 +0.67 (+3.87%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)CurrentInstitutional OwnershipPercentage91.89%Number ofInstitutional Buyers(last 12 months)45TotalInstitutional Inflows(last 12 months)$212.12MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.93M Get TRML Insider Trade Alerts Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRML Institutional Buying and Selling by Quarter Tourmaline Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2025 SG Americas Securities LLC34,812$706K0.0%+3.4%0.136% 1/15/2025 Brooklyn Investment Group1,576$32K0.0%N/A0.006% 12/26/2024JPMorgan Chase & Co.14,804$381K0.0%+16.5%0.058% 11/19/2024Barclays PLC31,833$819K0.0%+283.7%0.124% 11/16/2024Geode Capital Management LLC482,078$12.40M0.0%+6.4%1.880% 11/15/2024Barclays PLC31,833$819K0.0%+283.7%0.124% 11/15/2024Jane Street Group LLC21,705$558K0.0%-211.3%0.085% 11/15/2024Wellington Management Group LLP65,741$1.69M0.0%+72.8%0.256% 11/15/2024State Street Corp411,980$10.59M0.0%+25.6%1.607% 11/15/2024Point72 Asset Management L.P.338,437$8.70M0.0%N/A1.320% Get the Latest News and Ratings for TRML and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024Acuta Capital Partners LLC332,095$8.54M6.9%+23.2%1.295% 11/14/2024MetLife Investment Management LLC13,886$357K0.0%N/A0.054% 11/13/2024BNP Paribas Financial Markets13,348$343K0.0%-7.8%0.052% 11/13/2024FMR LLC15,063$387K0.0%-93.6%0.059% 11/13/2024The Manufacturers Life Insurance Company8,804$226K0.0%N/A0.034% 11/12/2024Charles Schwab Investment Management Inc.63,571$1.63M0.0%+3.5%0.248% 11/8/2024Jennison Associates LLC1,151,973$29.62M0.0%+2.2%4.493% 11/7/2024Quest Partners LLC9,381$241K0.0%+145.4%0.037% 10/30/2024AlphaCentric Advisors LLC5,500$141K0.1%-92.7%0.021% 10/25/2024China Universal Asset Management Co. Ltd.4,932$127K0.0%+63.7%0.019% 9/16/2024Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/16/2024Algert Global LLC39,866$513K0.0%+122.7%0.155% 8/15/2024Blue Owl Capital Holdings LP1,715,401$22.06M6.2%+18.5%6.689% 8/14/2024Cubist Systematic Strategies LLC37,861$487K0.0%N/A0.148% 8/14/2024Marshall Wace LLP170,447$2.19M0.0%+22.3%0.665% 8/14/2024HighVista Strategies LLC83,397$1.07M0.4%+57.2%0.325% 8/9/2024Renaissance Technologies LLC100,076$1.29M0.0%+184.9%0.390% 8/6/2024Quest Partners LLC3,822$49K0.0%+134.0%0.015% 8/1/2024Rhumbline Advisers33,239$427K0.0%+28,554.3%0.130% 7/26/2024Bank of New York Mellon Corp70,697$909K0.0%N/A0.276% 7/26/2024AlphaCentric Advisors LLC75,000$964K0.7%+22.7%0.292% 7/12/2024 SG Americas Securities LLC33,666$433K0.0%N/A0.131% 5/17/2024Artal Group S.A.314,496$7.20M0.2%+244.0%1.226% 5/16/2024California State Teachers Retirement System14,578$334K0.0%N/A0.057% 5/16/2024Janus Henderson Group PLC11,593$266K0.0%N/A0.045% 5/15/2024Darwin Global Management Ltd.465,000$10.65M1.4%N/A1.813% 5/15/2024Avoro Capital Advisors LLC2,222,222$50.89M0.6%+155.9%8.664% 5/15/2024Altitude Crest Partners Inc.47,400$1.09M0.5%N/A0.185% 5/15/2024Affinity Asset Advisors LLC50,000$1.15M0.1%-26.6%0.195% 5/14/2024Qiming U.S. Ventures Management LLC741,691$16.99M18.9%+15.6%2.892% Must-See: 5-Second Trump Prediction (Ad)President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.Click here now to get the details because you must act before January 20th.5/14/2024Nan Fung Group Holdings Ltd20,987$481K0.4%N/A0.082% 5/14/2024StemPoint Capital LP274,219$6.28M1.7%N/A1.069% 5/10/2024Vanguard Group Inc.914,519$20.94M0.0%+19.7%3.566% 5/7/2024Swiss National Bank32,000$733K0.0%N/A0.125% 5/2/2024Jennison Associates LLC1,115,251$25.54M0.0%N/A4.348% 5/1/2024BNP Paribas Financial Markets1,346$31K0.0%N/A0.005% 4/29/2024China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019% 4/19/2024Denali Advisors LLC5,600$128K0.0%N/A0.022% 2/15/2024Great Point Partners LLC672,885$17.62M3.0%N/A3.308% 2/14/2024Braidwell LP906,820$23.74M0.9%N/A4.458% 2/14/2024Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269% 2/14/2024RTW Investments LP398,850$10.44M0.2%N/A1.961% 2/13/2024Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335% 2/7/2024Jump Financial LLC14,500$380K0.0%N/A0.071% 2/7/2024Vivo Capital LLC591,882$15.50M1.3%N/A2.910% 1/30/2024BML Capital Management LLC245,500$6.43M4.9%N/A1.207% (Data available from 1/1/2016 forward) TRML Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRML shares? During the previous two years, 46 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Avoro Capital Advisors LLC ($50.89M), Jennison Associates LLC ($29.62M), Braidwell LP ($23.74M), Blue Owl Capital Holdings LP ($22.06M), Vanguard Group Inc. ($20.94M), Great Point Partners LLC ($17.62M), and Qiming U.S. Ventures Management LLC ($16.99M).Learn more on TRML's institutional investors. What percentage of Tourmaline Bio stock is owned by institutional investors? 91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings. Which institutional investors have been buying Tourmaline Bio stock? Of the 45 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($2.22M), Jennison Associates LLC ($1.14M), Braidwell LP ($906.82K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), Darwin Global Management Ltd. ($465K), and RTW Investments LP ($398.85K). How much institutional buying is happening at Tourmaline Bio? Institutional investors have bought a total of 8,921,989 shares in the last 24 months. This purchase volume represents approximately $212.12M in transactions. Which Tourmaline Bio major shareholders have been selling company stock? The following institutional investors have sold Tourmaline Bio stock in the last 24 months: FMR LLC ($221.67K), AlphaCentric Advisors LLC ($69.50K), Affinity Asset Advisors LLC ($18.08K), and BNP Paribas Financial Markets ($1.13K). How much institutional selling is happening at Tourmaline Bio? Institutional investors have sold a total of 310,378 shares in the last 24 months. This volume of shares sold represents approximately $7.93M in transactions. Related Companies IDEAYA Biosciences Major Shareholders Mesoblast Major Shareholders Agios Pharmaceuticals Major Shareholders Apogee Therapeutics Major Shareholders Amphastar Pharmaceuticals Major Shareholders Tarsus Pharmaceuticals Major Shareholders Iovance Biotherapeutics Major Shareholders Disc Medicine Major Shareholders ImmunityBio Major Shareholders Wave Life Sciences Major Shareholders This page (NASDAQ:TRML) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
